Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
J. Mebis, S. Vandeplassche, H. Goossens & Z.N. Berneman. (2009) CEFEPIME AND AMIKACIN AS EMPIRICAL THERAPY IN PATIENTS WITH FEBRILE NEUTROPAENIA: A SINGLE-CENTRE PHASE II PROSPECTIVE SURVEY. Acta Clinica Belgica 64:1, pages 35-41.
Read now
Read now
Honar Cherif, Magnus Björkholm, Per Engervall, Peter Johansson, Per Ljungman, Robert Hast & Mats Kalin. (2004) A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Scandinavian Journal of Infectious Diseases 36:8, pages 593-600.
Read now
Read now
L. Agaoglu, O. Devecioglu, S. Anak, Z. Karakas, N. Yalman, B. Biner, E. Eryilmaz, B. Goksan, A. Unuvar, H. Agirbasli, M. Can, H. Bilgen & G. Gedikoglu. (2001) Cost-Effectiveness of Cefepime + Netilmicin or Ceftazidime + Amikacin or Meropenem Monotherapy in Febrile Neutropenic Children with Malignancy in Turkey. Journal of Chemotherapy 13:3, pages 281-287.
Read now
Read now
Articles from other publishers (8)
Helen L. Leather & John R. Wingard. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
1038
1062
.
Tiphaine Goulenok & Bruno Fantin. (2013) Antimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic–Pharmacodynamic Considerations. Clinical Pharmacokinetics 52:10, pages 869-883.
Crossref
Crossref
Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz, Michael J. Boeckh, James I. Ito, Craig A. Mullen, Issam I. Raad, Kenneth V. Rolston, Jo-Anne H. Young & John R. Wingard. (2011) Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 52:4, pages e56-e93.
Crossref
Crossref
Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz, Michael J. Boeckh, James I. Ito, Craig A. Mullen, Issam I. Raad, Kenneth V. Rolston, Jo-Anne H. Young & John R. Wingard. (2011) Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 52:4, pages 427-431.
Crossref
Crossref
Antonio Jimeno, Alberto Arcediano, Susana Bezares, María Luz Amador, Lucía González-Cortijo, Eva Ciruelos, Luis Robles, Daniel Castellano, Luis Paz-Ares, Carlos Lumbreras, Javier Hornedo & Hernán Cortés-Funes. (2006) Randomized Study of Cefepime versus Ceftazidime plus Amikacin in Patients with Solid Tumors Treated with High Dose Chemotherapy (HDC) and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia. Clinical and Translational Oncology 8:12, pages 889-895.
Crossref
Crossref
John R. Wingard & Helen L. Leather. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation
665
682
.
Paolo Furno, Giampaolo Bucaneve & Albano Del Favero. (2002) Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. The Lancet Infectious Diseases 2:4, pages 231-242.
Crossref
Crossref
Walter T. Hughes, Donald Armstrong, Gerald P. Bodey, Eric J. Bow, Arthur E. Brown, Thierry Calandra, Ronald Feld, Philip A. Pizzo, Kenneth V. I. Rolston, Jerry L. Shenep & Lowell S. Young. (2002) 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer. Clinical Infectious Diseases 34:6, pages 730-751.
Crossref
Crossref